Juszczak Kajetan, Drewa Tomasz
Department of Urology, Rydygier Memorial Hospital, Cracow, Poland ; Department of Pathophysiology, Jagiellonian University, Medical College, Cracow, Poland.
Department of Regenerative Medicine, Medical College, Nicolaus Copernicus University, Toruń, Poland ; Department of Urology, Nicolaus Copernicus University, Toruń, Poland.
Cent European J Urol. 2014;67(2):153-5. doi: 10.5173/ceju.2014.02.art7. Epub 2014 Jun 23.
The definitive therapy in case of pheochromocytoma is complete surgical resection. Improper preoperative assessment and medical management generally places the patient at risk for complications, resulting from an adrenergic crisis. Therefore, it is crucial to adequately optimize these patients before surgery. Optimal preoperative medical management significantly decreases morbidity and mortality during the tumor resection.
This review addresses current knowledge in pre- and intraoperative assessment of a patient with pheochromocytoma.
Before surgery the patient is conventionally prepared with α-adrenergic blockade (over 10-14 days) and subsequently, additional β-adrenergic blockade is required to treat any associated tachyarrhythmias. In preoperative assessment, it is obligatory to monitor arterial blood pressure, heart rate, and arrhythmias and to restore the blood volume to normal.
In conclusion, due to the pathophysiological complexity of a pheochromocytoma, the strict cooperation between the cardiologist, endocrinologist, surgeon and the anaesthesiologist for an uneventful outcome should be achieved in patients qualified for the surgical removal of such a tumor.
嗜铬细胞瘤的 definitive 治疗方法是完整的手术切除。术前评估和医疗管理不当通常会使患者面临由肾上腺素能危象导致的并发症风险。因此,在手术前充分优化这些患者的状况至关重要。最佳的术前医疗管理可显著降低肿瘤切除期间的发病率和死亡率。
本综述阐述了嗜铬细胞瘤患者术前和术中评估的当前知识。
手术前,患者通常先进行α-肾上腺素能阻滞(持续10 - 14天),随后,需要额外进行β-肾上腺素能阻滞来治疗任何相关的快速性心律失常。在术前评估中,必须监测动脉血压、心率和心律失常,并使血容量恢复正常。
总之,由于嗜铬细胞瘤的病理生理复杂性,对于有资格接受此类肿瘤手术切除的患者,心脏病专家、内分泌专家、外科医生和麻醉医生之间应紧密合作,以实现平稳的治疗结果。